SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-057631
Filing Date
2023-12-06
Accepted
2023-12-06 16:50:40
Documents
2
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1624
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3696
  Complete submission text file 0001209191-23-057631.txt   6645
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 321 HARRISON AVENUE 11TH FLOOR, SUITE 1 BOSTON MA 02118
Business Address
Kobayashi Ken (Reporting) CIK: 0002003383 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40881 | Film No.: 231470291